DAL vs SPRO · P/E 12, rev $61.64B vs P/E 9.6, rev $48.0M
Delta Air Lines Inc (DAL) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the DAL and SPRO stock pages for the full models.
Not investment advice.